6th Annual TIL Therapies Summit

Following the watershed approval of Iovance’s Lifileucel, all eyes are now on TIL therapies as the up-and-coming major therapeutic avenue for solid tumor treatment. Introducing the 6th Annual TIL Therapies Summit! With 30+ expert speakers, 12 new speaker companies, 2 brand-new content-filled tracks and 2 brand-new interactive workshops, you won't want to miss out! As the only meeting placing the entire spotlight on TIL drug development, this summit will unveil the latest to share clinical updates, next-generation candidates, manufacturing innovations, and assay characterizations to turbocharge development of the next wave of TIL therapies. Hear from TIL industry leaders like Iovance, MD Anderson Cancer Center, Obsidian Therapeutics, Steven Rosenberg’s group from the National Institute of Health and more, as they share ground-breaking TIL discoveries from R&D to commercialization. Join us in October to capitalize on this golden opportunity to ensure you and your entire team stay ahead of the TIL wave!